BioCrude Technologies USA, Inc. financial data

Location
1255 Phillips Square, Suite 605, Montreal, Quebec, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.68 % -91.4%
Debt-to-equity -105 % +10.3%
Return On Equity 108 % -9.12%
Return On Assets -1.41K % -104%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50.9M shares +0.01%
Common Stock, Shares, Outstanding 50.9M shares +0.01%
Entity Public Float 0 USD
Common Stock, Value, Issued 50.9K USD +0.01%
Weighted Average Number of Shares Outstanding, Basic 50.8M shares +0%
Weighted Average Number of Shares Outstanding, Diluted 50.8M shares +0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
General and Administrative Expense 201K USD -19.3%
Operating Income (Loss) -201K USD +19.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -208K USD +18.1%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 109 USD -99.7%
Property, Plant and Equipment, Net 10.3K USD -25.5%
Assets 10.4K USD -78.9%
Liabilities, Current 459K USD +50.7%
Liabilities 459K USD +50.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 27.5K USD -4.11%
Retained Earnings (Accumulated Deficit) -9.62M USD -2.21%
Stockholders' Equity Attributable to Parent -445K USD -76.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -303K USD -27.3%
Liabilities and Equity 10.4K USD -78.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -30.1K USD +62%
Net Cash Provided by (Used in) Financing Activities 30.1K USD -62.1%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 50.9M shares +0.01%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -26K USD -1550%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 109 USD +43.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 476K USD +13.9%
Depreciation 1.21K USD +11.9%
Payments to Acquire Property, Plant, and Equipment 0 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -38.6K USD -33.5%
Property, Plant and Equipment, Gross 37.4K USD +3.64%
Additional Paid in Capital 9.1M USD +0.18%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 6.98K USD +42.3%